ALNY
#444
Alnylam Pharmaceuticals, Inc. - Common Stock
236.5 6 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.02%
Monthly Change
-17.82%
6 month change
-27.95%
Year Change
-47.73%
Previous Close
239.0 0
Open
236.4 2
Low
236.4 2
High
236.5 6
Volume
226
Financials
- Market Capitalization 31.65 B
- Employee 2 500
- Founded 2002
- CEO Yvonne Greenstreet
- Website www.alnylam.com
- Headquarter Massachusetts, United States
- FIGI BBG000BFGNJ5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
170.67
Price to sales ratio
14.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 290 |  MRNA Moderna, Inc. - Common Stock | 142.77 USD | -4.60% | +7.75% | +159.39% | +488.50% | 57.00 B USD | ||
| 339 |  RVMD Revolution Medicines, Inc. - Common Stock | 221.15 USD | +2.65% | +4.55% | +20.07% | +299.19% | 47.40 B USD | ||
| 485 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.92 USD | +0.19% | +2.30% | +3.36% | +66.18% | 27.65 B USD | ||
| 492 |  ROIV Roivant Sciences Ltd. - Common Shares | 37.58 USD | +2.26% | +1.49% | +10.89% | +105.24% | 27.14 B USD |
Frequently asked questions about Alnylam Pharmaceuticals, Inc.
What is the Alnylam Pharmaceuticals, Inc. stock price today?
The current price of Alnylam Pharmaceuticals, Inc. (ALNY) is 236.56. Over the past 24 hours, the stock has changed by -1.02%. Follow the ALNY chart for real-time price dynamics.
What is the stock ticker of Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. trades under the ticker ALNY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Alnylam Pharmaceuticals, Inc. stock going up?
ALNY has changed by +3.36% over the last week, -17.82% over the last month, and -47.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. currently has a market capitalization of 31.65 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Alnylam Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Alnylam Pharmaceuticals, Inc. reported earnings of 1.23 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Alnylam Pharmaceuticals, Inc. revenue for the last quarter?
Alnylam Pharmaceuticals, Inc. reported quarterly revenue of 1.29 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Alnylam Pharmaceuticals, Inc. net income for the last quarter?
Alnylam Pharmaceuticals, Inc. reported net income of 164.49 M for the last quarter. The previous quarter showed 205.99 M, which means net income changed by -20.15%.
How many employees does Alnylam Pharmaceuticals, Inc. have?
As of the latest available data, Alnylam Pharmaceuticals, Inc. has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Alnylam Pharmaceuticals, Inc. stock?
You can buy Alnylam Pharmaceuticals, Inc. (ALNY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Alnylam Pharmaceuticals, Inc. stock?
Investing in Alnylam Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALNY chart and related analysis on metatrader.com as part of your research.